These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35065233)

  • 1. Amyloidogenic immunoglobulin light chain kinetic stabilizers comprising a simple urea linker module reveal a novel binding sub-site.
    Yan NL; Nair R; Chu A; Wilson IA; Johnson KA; Morgan GJ; Kelly JW
    Bioorg Med Chem Lett; 2022 Mar; 60():128571. PubMed ID: 35065233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the stabilization of amyloidogenic immunoglobulin light chains by hydantoins.
    Yan NL; Santos-Martins D; Rennella E; Sanchez BB; Chen JS; Kay LE; Wilson IA; Morgan GJ; Forli S; Kelly JW
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127356. PubMed ID: 32631553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent Coumarin-Based Kinetic Stabilizers of Amyloidogenic Immunoglobulin Light Chains Using Structure-Based Design.
    Yan NL; Santos-Martins D; Nair R; Chu A; Wilson IA; Johnson KA; Forli S; Morgan GJ; Petrassi HM; Kelly JW
    J Med Chem; 2021 May; 64(9):6273-6299. PubMed ID: 33939422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
    Morgan GJ; Kelly JW
    J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of amyloidogenic immunoglobulin light chains by small molecules.
    Morgan GJ; Yan NL; Mortenson DE; Rennella E; Blundon JM; Gwin RM; Lin CY; Stanfield RL; Brown SJ; Rosen H; Spicer TP; Fernandez-Vega V; Merlini G; Kay LE; Wilson IA; Kelly JW
    Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8360-8369. PubMed ID: 30971495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological stabilization of the native state of full-length immunoglobulin light chains to treat light chain amyloidosis.
    Yan NL; Morgan GJ; Petrassi HM; Wilson IA; Kelly JW
    Curr Opin Chem Biol; 2023 Aug; 75():102319. PubMed ID: 37279624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain.
    Klimtchuk ES; Gursky O; Patel RS; Laporte KL; Connors LH; Skinner M; Seldin DC
    Biochemistry; 2010 Nov; 49(45):9848-57. PubMed ID: 20936823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
    Weber B; Hora M; Kazman P; Göbl C; Camilloni C; Reif B; Buchner J
    J Mol Biol; 2018 Dec; 430(24):4925-4940. PubMed ID: 30414962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
    Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J
    J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.
    Oberti L; Rognoni P; Barbiroli A; Lavatelli F; Russo R; Maritan M; Palladini G; Bolognesi M; Merlini G; Ricagno S
    Sci Rep; 2017 Dec; 7(1):16809. PubMed ID: 29196671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains.
    Kim YS; Cape SP; Chi E; Raffen R; Wilkins-Stevens P; Stevens FJ; Manning MC; Randolph TW; Solomon A; Carpenter JF
    J Biol Chem; 2001 Jan; 276(2):1626-33. PubMed ID: 11050093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis.
    Morgan GJ; Buxbaum JN; Kelly JW
    Hemato; 2021 Dec; 2(4):645-659. PubMed ID: 35757512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
    Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
    FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
    Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
    Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity.
    Choi S; Reixach N; Connelly S; Johnson SM; Wilson IA; Kelly JW
    J Am Chem Soc; 2010 Feb; 132(4):1359-70. PubMed ID: 20043671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation.
    Broggini L; Barzago MM; Speranzini V; Schulte T; Sonzini F; Giono M; Romeo M; Milani P; Caminito S; Mazzini G; Rognoni P; Merlini G; Pappone C; Anastasia L; Nuvolone M; Palladini G; Diomede L; Ricagno S
    J Mol Biol; 2023 Dec; 435(24):168320. PubMed ID: 37865287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of domain interactions in the aggregation of full-length immunoglobulin light chains.
    Rennella E; Morgan GJ; Kelly JW; Kay LE
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):854-863. PubMed ID: 30598439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete Refolding of Antibody Light Chains to Non-Native, Protease-Sensitive Conformations Leads to Aggregation: A Mechanism of Amyloidogenesis in Patients?
    Morgan GJ; Usher GA; Kelly JW
    Biochemistry; 2017 Dec; 56(50):6597-6614. PubMed ID: 29200282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Conservative Point Mutation in a Dynamic Antigen-binding Loop of Human Immunoglobulin λ6 Light Chain Promotes Pathologic Amyloid Formation.
    Peterle D; Klimtchuk ES; Wales TE; Georgescauld F; Connors LH; Engen JR; Gursky O
    J Mol Biol; 2021 Dec; 433(24):167310. PubMed ID: 34678302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.
    Russo R; Romeo M; Schulte T; Maritan M; Oberti L; Barzago MM; Barbiroli A; Pappone C; Anastasia L; Palladini G; Diomede L; Ricagno S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.